148 related articles for article (PubMed ID: 34942513)
21. CD98 increases renal epithelial cell proliferation by activating MAPKs.
Bulus N; Feral C; Pozzi A; Zent R
PLoS One; 2012; 7(6):e40026. PubMed ID: 22768207
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-Analysis.
Zhang C; Xu J; Xue S; Ye J
Mol Diagn Ther; 2020 Oct; 24(5):523-536. PubMed ID: 32410110
[TBL] [Abstract][Full Text] [Related]
23.
Feral CC; Tissot FS; Tosello L; Fakhry N; Sebag F; Pacak K; Taïeb D
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):812-821. PubMed ID: 27900521
[TBL] [Abstract][Full Text] [Related]
24. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2009 Feb; 100(2):248-54. PubMed ID: 19068093
[TBL] [Abstract][Full Text] [Related]
26. The membrane-spanning domain of CD98 heavy chain promotes alpha(v)beta3 integrin signals in human extravillous trophoblasts.
Kabir-Salmani M; Fukuda MN; Kanai-Azuma M; Ahmed N; Shiokawa S; Akimoto Y; Sakai K; Nagamori S; Kanai Y; Sugihara K; Iwashita M
Mol Endocrinol; 2008 Mar; 22(3):707-15. PubMed ID: 18032696
[TBL] [Abstract][Full Text] [Related]
27. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
[TBL] [Abstract][Full Text] [Related]
28. L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.
Ichinoe M; Yanagisawa N; Mikami T; Hana K; Nakada N; Endou H; Okayasu I; Murakumo Y
Pathol Res Pract; 2015 Jul; 211(7):533-8. PubMed ID: 25908107
[TBL] [Abstract][Full Text] [Related]
29. Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis.
Furuya M; Horiguchi J; Nakajima H; Kanai Y; Oyama T
Cancer Sci; 2012 Feb; 103(2):382-9. PubMed ID: 22077314
[TBL] [Abstract][Full Text] [Related]
30. Positive correlation of expression of L-type amino-acid transporter 1 with colorectal tumor progression and prognosis: Higher expression in sporadic colorectal tumors compared with ulcerative colitis-associated neoplasia.
Sakata T; Hana K; Mikami T; Yoshida T; Endou H; Okayasu I
Pathol Res Pract; 2020 Jun; 216(6):152972. PubMed ID: 32359697
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target.
Hayashi N; Yamasaki A; Ueda S; Okazaki S; Ohno Y; Tanaka T; Endo Y; Tomioka Y; Masuko K; Masuko T; Sugiura R
Oncotarget; 2021 Jun; 12(13):1256-1270. PubMed ID: 34194623
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
Exp Ther Med; 2010 Sep; 1(5):799-808. PubMed ID: 22993604
[TBL] [Abstract][Full Text] [Related]
33. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
Asano S; Kameyama M; Oura A; Morisato A; Sakai H; Tabuchi Y; Chairoungdua A; Endou H; Kanai Y
Biol Pharm Bull; 2007 Mar; 30(3):415-22. PubMed ID: 17329830
[TBL] [Abstract][Full Text] [Related]
34. Expression of LAT1 and 4F2hc in Gastroenteropancreatic Neuroendocrine Neoplasms.
Horita Y; Kaira K; Kawasaki T; Mihara Y; Sakuramoto S; Yamaguchi S; Okamoto K; Ryozawa S; Kanai Y; Yasuda M; Hamaguchi T
In Vivo; 2021; 35(4):2425-2432. PubMed ID: 34182526
[TBL] [Abstract][Full Text] [Related]
35. Cooperation of Antiporter LAT2/CD98hc with Uniporter TAT1 for Renal Reabsorption of Neutral Amino Acids.
Vilches C; Boiadjieva-Knöpfel E; Bodoy S; Camargo S; López de Heredia M; Prat E; Ormazabal A; Artuch R; Zorzano A; Verrey F; Nunes V; Palacín M
J Am Soc Nephrol; 2018 Jun; 29(6):1624-1635. PubMed ID: 29610403
[No Abstract] [Full Text] [Related]
36. CD98 heavy chain as a prognostic biomarker and target for cancer treatment.
Xia P; Dubrovska A
Front Oncol; 2023; 13():1251100. PubMed ID: 37823053
[TBL] [Abstract][Full Text] [Related]
37. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
Digomann D; Linge A; Dubrovska A
Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
[TBL] [Abstract][Full Text] [Related]
38. Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
Khunweeraphong N; Nagamori S; Wiriyasermkul P; Nishinaka Y; Wongthai P; Ohgaki R; Tanaka H; Tominaga H; Sakurai H; Kanai Y
J Pharmacol Sci; 2012; 119(4):368-80. PubMed ID: 22850614
[TBL] [Abstract][Full Text] [Related]
39. Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Ogata S; Matsuo H; Kanai Y; Endou H; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Kawai T
Virchows Arch; 2007 Sep; 451(3):681-90. PubMed ID: 17622555
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes.
Ueda S; Hayashi H; Miyamoto T; Abe S; Hirai K; Matsukura K; Yagi H; Hara Y; Yoshida K; Okazaki S; Tamura M; Abe Y; Agatsuma T; Niwa SI; Masuko K; Masuko T
Cancer Sci; 2019 Feb; 110(2):674-685. PubMed ID: 30548114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
